Arvinas (ARVN) EBITDA Margin (2017 - 2026)
Arvinas (ARVN) reported EBITDA Margin of 67.28% for Q2 2026, up 381.12 percentage points from -313.84% a year earlier and up 469.84 percentage points from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) EBITDA Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arvinas' EBITDA Margin came in at -3.50%, up 25.55 percentage points year-over-year; for FY2025, it came in at -42.35%, up 49.15 percentage points from FY2024.
- EBITDA Margin has a five-year change of +411.71 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -91.50% in FY2024 (+412.20 pp), -503.69% in FY2023 (-309.55 pp), -194.14% in FY2022 (+147.65 pp) and -341.79% in FY2021 (+112.26 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin in data going back to Q3 2017.
- Year over year, EBITDA Margin gained in three of the last seven quarters, with an average year-over-year change of -75.18 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q2 2022 (a gain of 733.06 percentage points); the low point was Q4 2025 (a drop of 681.03 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -402.56% (Q1 2026), -775.79% (Q4 2025) and -101.67% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Arvinas | 490.21 Mn | -2.17 Bn | - | 67.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.28% |
| Mar 31, 2026 | -402.56% |
| Dec 31, 2025 | -775.79% |
| Sep 30, 2025 | -101.67% |
| Jun 30, 2025 | -313.84% |
| Mar 31, 2025 | 39.94% |
| Dec 31, 2024 | -94.76% |
| Sep 30, 2024 | -55.96% |
| Jun 30, 2024 | -60.13% |
| Mar 31, 2024 | -322.92% |
| Sep 30, 2023 | -208.67% |
| Jun 30, 2023 | -133.03% |
| Mar 31, 2023 | -264.31% |
| Dec 31, 2022 | -194.18% |
| Sep 30, 2022 | -187.35% |
| Jun 30, 2022 | -188.76% |
| Mar 31, 2022 | -210.94% |
| Dec 31, 2021 | -138.25% |
| Sep 30, 2021 | -494.62% |
| Jun 30, 2021 | -921.82% |
API Access
Arvinas EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();